MedTrace Logo

A Combination Triple Pill Implementation Strategy for Blood Pressure cONtrol

NCT07784647 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1357

Last updated 2026-08-31

No results posted yet for this study

Summary

This study includes a survey of primary healthcare facilities in Nigeria and Sri Lanka. It will aim to assess the availability and readiness of hypertension care in primary healthcare facilities, and feasibility to conduct a future randomised controlled trial.

This study also includes a survey of patients with high blood pressure who will be recruited from primary care in Sri Lanka and Nigeria. Its aim is to understand the characteristics of patients with hypertension, hypertension management and control, including use of pharmacological interventions and lifestyle management. Patients will have their blood pressure, height and weight measured. They will also be asked about their age, sex/gender, socio-economic status, medical history, and health behaviours and lifestyle.

Additionally, this study includes focus group discussions and in-depth interviews with adults with high blood pressure and their carers; healthcare providers (community health workers, nurses, and doctors or physicians); clinic administrators; and policymakers. The discussions and interviews will aim to explore experiences, practices, and views on hypertension care and the new treatment strategies. Topics will cover experiences of current high blood pressure care; service availability, accessibility, and affordability; healthcare staff training and how well they follow medical guidelines for helping patients with high blood pressure; what works well and what are the problems with helping patients with high blood pressure; experiences of patients who need help with their high blood pressure; and how well new ways of helping people with high blood pressure are received.

Conditions

Sponsors & Collaborators

  • University of Abuja

    collaborator OTHER

  • RemediumOne

    collaborator UNKNOWN

  • University of Kelaniya

    collaborator OTHER

  • The George Institute

    collaborator OTHER

  • The George Institute for Global Health, Australia

    collaborator OTHER

  • The University of New South Wales

    collaborator OTHER

  • Imperial College London

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • Nigeria
  • Sri Lanka

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07784647 on ClinicalTrials.gov